Learn how the IQVIA Investigator Site Portal reduces activation timelines and eliminates site frustrations by automating processes and providing complete oversight to study teams.
Learn how teams can leverage organizational, procedural, and technological solutions to recapture valuable days, weeks, and even months in the activation timelines of research sites.
The sponsor-site relationship relies on good faith, but late payments sow mistrust. Experts from BMS and CenExel Clinical Research explain how consolidating payment systems benefits both parties.
IQVIA, a leading health information technology and clinical research company, has introduced a new validation model for eTMF patterned after approaches used within the larger tech space.
Learn to expedite UAT through objective evidence exchange, decreased individual workloads for participating sponsors, increased access to users, and faster, more reliable testing.
An approach most often seen in the larger tech space, crowdsource UAT can offer several potential advantages for the clinical trial industry and eTMF validation.
How do payment systems affect site-sponsor relationships? George Kourtsounis of Bristol Myers Squibb and Casey Orvin of CenExel Clinical Research lend their expertise to this question and more.
Paying clinical trial sites consistently on time provides stability and maintains positive relationships. Learn why being a sponsor of choice can mean the adoption of a singular clinical trial payments solution.
Listen in as leaders from Bristol Myers Squibb, CenExel Centers of Excellence, and IQVIA Technologies discuss the importance of providing a consistent clinical trial payment experience to sites.
Unearth how bringing the functions of medical writing, clinical data management, and electronic data capture can positively impact the creation of a budget and payment process.
Get the latest articles from Clinical Leader delivered to your inbox.